Compare Immunovant Inc. Common Stock (IMVT) vs Magna International Inc. Common Stock (MGA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Magna International Inc. Common Stock — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while Magna International Inc. Common Stock trades at $63.7 (market cap $17.43B). The key difference: Magna International Inc. Common Stock is far larger — about 2.6× Immunovant Inc. Common Stock's market cap, and Magna International Inc. Common Stock pays a 3.04% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Magna International Inc. Common Stock for 0 Days on average.
| IMVT | MGA | |
|---|---|---|
Market Cap | $6.62B | $17.43B |
Volume | 1,131,364 | 1,096,759 |
Sector | Health | Consumer Cyclical |
52-Week High | $44.96 | $73.05 |
52-Week Low | $17.03 | $43.54 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.72B | $22.47B |
Dividend Yield | — | 3.04% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Magna International Inc. Common Stock
Magna International Inc. is a Canada-based automotive supplier that designs, engineers, and manufactures vehicle systems and components, including body and chassis structures, seating, powertrain, and electronics, and provides complete-vehicle engineering and contract assembly, with manufacturing operations in 28 countries.
Read more on MGA →
